An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.
An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.
复制标题
烯醇酶抑制剂,用于靶向ENO1删除的癌症。
DOI:
10.1038/s42255-020-00313-3
复制
发表时间:
2020-12
影响因子:
20.8
通讯作者:
Muller FL
中科院分区:
文献类型:
--
作者:
Lin YH;Satani N;Hammoudi N;Yan VC;Barekatain Y;Khadka S;Ackroyd JJ;Georgiou DK;Pham CD;Arthur K;Maxwell D;Peng Z;Leonard PG;Czako B;Pisaneschi F;Mandal P;Sun Y;Zielinski R;Pando SC;Wang X;Tran T;Xu Q;Wu Q;Jiang Y;Kang Z;Asara JM;Priebe W;Bornmann W;Marszalek JR;DePinho RA;Muller FL
Inhibiting glycolysis remains an aspirational approach for the treatment of cancer. We previously identified a subset of cancers harboring homozygous deletion of the glycolytic enzyme Enolase (ENO1) with exceptional sensitivity to inhibition of its redundant paralogue, ENO2, through a therapeutic strategy known as collateral lethality. Here, we show that a small molecule Enolase inhibitor, POMHEX, can selectively kill ENO1-deleted glioma cells at low nanomolar concentrations and eradicate intracranial orthotopic ENO1-deleted tumors in mice at doses well-tolerated in non-human primates. Our data provide in vivo proof-of-principal for the power of collateral lethality in precision oncology and demonstrate the utility of POMHEX for glycolysis inhibition with potential across a range of therapeutic settings.
登录
查看更多内容
影响因子:
2.9
作者:
ANDERSON, VE;WEISS, PM;CLELAND, WW
通讯作者:
CLELAND, WW
影响因子:
2.7
作者:
Fonvielle, M;Mariano, S;Therisod, M
通讯作者:
Therisod, M
DOI:
10.1107/s0907444909052925
发表时间:
2010-02
期刊:
Acta crystallographica. Section D, Biological crystallography
影响因子:
--
作者:
Adams PD;Afonine PV;Bunkóczi G;Chen VB;Davis IW;Echols N;Headd JJ;Hung LW;Kapral GJ;Grosse-Kunstleve RW;McCoy AJ;Moriarty NW;Oeffner R;Read RJ;Richardson DC;Richardson JS;Terwilliger TC;Zwart PH
通讯作者:
Zwart PH
影响因子:
15.9
作者:
Bady, Pierre;Diserens, Annie-Claire;Hegi, Monika E.
通讯作者:
Hegi, Monika E.
影响因子:
8.6
作者:
Gaffney, Dominique O.;Jennings, Erin Q.;Galligan, James J.
通讯作者:
Galligan, James J.